Literature DB >> 3555432

Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?

F Cambien, J M Warnet, E Eschwege, A Jacqueson, J L Richard, G Rosselin.   

Abstract

Obesity, hypertension, a high plasma level of glucose, and some lipid abnormalities (high plasma levels of cholesterol and triglycerides) often occur in the same individuals. Some authors have postulated that the elevated levels of plasma insulin in obese individuals may explain this association. To explore this hypothesis further, the relationships between body mass index, fasting plasma glucose and insulin, blood pressure, serum lipids, and apoproteins were investigated in a group of 2144 healthy middle-aged men. Analysis of the data show that the associations between body mass index and blood pressure or lipid variables are largely independent of plasma glucose and insulin. Plasma glucose is strongly related to blood pressure in nonobese subjects. Plasma insulin is not associated with blood pressure independently of body mass index and plasma glucose; however, the simultaneous elevation of body mass index, plasma glucose, and insulin is strongly associated with blood pressure. The results also confirm that plasma insulin is positively related to triglycerides and negatively related to high density lipoprotein cholesterol independently of plasma glucose and body mass index.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555432     DOI: 10.1161/01.atv.7.2.197

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  10 in total

1.  The relation of fetal growth to plasma glucose in young men.

Authors:  S Robinson; R J Walton; P M Clark; D J Barker; C N Hales; C Osmond
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

2.  Does impaired glucose tolerance predict hypertension? A prospective analysis.

Authors:  O Vaccaro; G Imperatore; V Iovino; C Iovine; A A Rivellese; G Riccardi
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

3.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loading.

Authors:  Kenji Ishibashi; Keiichi Kawasaki; Kiichi Ishiwata; Kenji Ishii
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

5.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

6.  Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

Authors:  D Giugliano; A Quatraro; A Minei; N De Rosa; L Coppola; F D'Onofrio
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

7.  Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.

Authors:  E J Feskens; J Tuomilehto; J H Stengård; J Pekkanen; A Nissinen; D Kromhout
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

8.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.

Authors:  J W Yarnell; P M Sweetnam; V Marks; J D Teale; C H Bolton
Journal:  Br Heart J       Date:  1994-03

9.  Plasma glucose and insulin responses to oral glucose loading in nonobese Nigerian subjects with essential hypertension.

Authors:  A O Akanji; A C Ojule; S Kadiri; B O Osotimehin
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

Review 10.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.